Company / R&D per Share
KYNTRA BIO, INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$23.70
FY2025
5-year range
$2.29 / $23.70
FY2021-FY2025
Trend
+778.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +779% YoY in FY2025, a notable deviation from the 9-year average annual change of +91%.
Based on SEC 10-K filings.
23.70 in FY2025 with a 5-year CAGR of +54.5%.
Improved from $4.11 to $23.70 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +105.7%
- 5-Year CAGR
- +54.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 778.6% year-over-year.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.33 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.70 | +778.6% |
| FY2024 | $2.70 | -34.4% |
| FY2023 | $4.11 | +50.9% |
| FY2022 | $2.72 | +19.0% |
| FY2021 | $2.29 | -14.9% |
| FY2020 | $2.69 | +17.0% |
| FY2019 | $2.30 | +1.4% |
| FY2018 | $2.27 | -32.5% |
| FY2017 | $3.36 | +38.2% |
| FY2016 | $2.43 | +67.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026